RNADERM THERAPEUTICS
RNADERM THERAPEUTICS
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Berkeley, California, United States
Country:
United States
Status:
Active
Contact:
(857) 222-4653
Total Funding:
750 K USD
Similar Organizations
AcureX Therapeutics
AcureX Therapeutics is a biotechnology company.
Savefruit
Savefruit is a biotechnology company.
Telum Therapeutics
Telum Therapeutics is a biotechnology company.
Current Employees Featured
Founder
More informations about "RNADerm Therapeutics"
RNADerm Therapeutics - Crunchbase Company Profile & Funding
RNADerm Therapeutics is a biotechnology company. Where is RNADerm Therapeutics's headquarters? RNADerm Therapeutics is located in Berkeley, California, United States. How …See details»
RNADerm Therapeutics - Funding, Financials, Valuation & Investors
RNADerm Therapeutics is a biotechnology company.See details»
RNADERM THERAPEUTICS, INC. :: California (US) - OpenCorporates
Jul 8, 2020 · Free and open company data on California (US) company RNADERM THERAPEUTICS, INC. (company number 4611270), 904 ALVARADO ROAD BERKELEY CA …See details»
Rnaderm Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Jun 28, 2023 · Explore Rnaderm Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
RNADerm Therapeutics - Crunchbase
Rekindle, Libra, Xios, Geom, and Primmune Therapeutics focus on developing therapeutic solutions for various diseases and medical conditions, while RNADerm Therapeutics …See details»
RNADerm Therapeutics - Products, Competitors, Financials, …
RNADerm Therapeutics is a Berkeley, California based biotechnology company operating in stealth. Use the CB Insights Platform to explore RNADerm Therapeutics's full profile.See details»
RNADerm Therapeutics Stock Price, Funding, Valuation, Revenue ...
See RNADerm Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on RNADerm Therapeutics's post-money valuation and revenue.See details»
RNA therapeutics on the rise - Nature
Apr 27, 2020 · RNA therapeutics have demonstrated most success in the treatment of rare diseases, especially neurological and hepatic diseases. Of the 21 late-stage RNA therapeutics, 18 have orphan status...See details»
RNA-based therapeutics: an overview and prospectus
Jul 23, 2022 · In this review, the mechanisms of action, challenges, solutions, and clinical application of RNA-based therapeutics have been comprehensively summarized.See details»
RNA therapy: rich history, various applications and unlimited …
Apr 19, 2022 · RNA therapy refers to the treatment or prevention of diseases using RNA-based molecules. The recent advent of a series of effective messenger RNA-based vaccines in …See details»
PTM-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 · PTM-001, Initially developed by Emory University, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Digestive System Disorders, Active Indication: Colitis, …See details»
The Limitless Future of RNA Therapeutics - PMC - PubMed Central …
In this review we discuss general concepts of different classes of RNA-based therapeutics, including antisense oligonucleotides, aptamers, small interfering RNAs, microRNAs, and …See details»
RNA Therapeutics: A Healthcare Paradigm Shift - PMC
Apr 25, 2023 · RNA therapeutics are a class of drug based on ribonucleic acid (RNA) that includes RNA aptamers, messenger RNA (mRNA), RNA interference (RNAi), and antisense …See details»
Nutcracker Therapeutics Presents Precision Biomanufacturing and …
3 days ago · EMERYVILLE, Calif., November 25, 2024--Nutcracker Therapeutics will introduce its CRDMO capabilities to provide scalable biomanufacturing services for RNA drug developers.See details»
How the RNAi therapeutic ‘operating system’ is rewriting ... - Nature
RNAi therapeutics are inspired by a mechanism that exists in all cells to regulate gene expression, using specially-designed small interfering RNA (siRNA) that is complementary to specific...See details»
Current Advances in RNA Therapeutics for Human Diseases
Current advances in RNA-based therapies have substantial promise in treating and preventing many human diseases and disorders through fixing the pathology instead of merely treating …See details»
RNA therapy: rich history, various applications and unlimited …
RNA therapy refers to the treatment or prevention of diseases using RNA-based molecules. The recent advent of a series of effective messenger RNA-based vaccines in response to the …See details»
Noncoding RNA therapeutics — challenges and potential …
Jun 18, 2021 · Therapeutic targeting of noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), represents an attractive approach for the …See details»
Advancements in clinical RNA therapeutics: Present developments …
May 21, 2024 · In this review, we explore the implications of RNAs in diseases and provide a chronological overview of the development of RNA therapeutics. Additionally, we summarize …See details»
Nutcracker Therapeutics at Personalized Cancer Vaccine Summit …
1 day ago · Nutcracker Therapeutics, a biotechnology company specializing in RNA therapies, announced its participation in the 2024 Personalized Cancer Vaccine Summit, showcasing its …See details»